DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata

被引:12
|
作者
Cormican, MG [1 ]
Hollis, RJ [1 ]
Pfaller, MA [1 ]
机构
[1] UNIV IOWA,COLL MED,DEPT PATHOL,DEPT MED MICROBIOL,IOWA CITY,IA 52242
关键词
D O I
10.1016/S0732-8893(96)00083-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Candida (Torulopsis) glabrata is an emerging nosocomial pathogen that may be relatively resistant to fluconazole. A series of 75 isolates (blood, urine, tissue, and other sites) from 16 patients (1 to 12 isolates per patient) at a single university medical center were analyzed by pulsed field gel electrophoresis (PFGE) of restriction endonuclease digests of chromosomal DNA. The MICs of the isolates for amphotericin B, flucytosine, fluconazole, and itraconazole, were determined by a microdilution broth method. A preliminary study of seven restriction enzymes, three producing small fragments (Hinf I, Hind III, Eco XI) and four producing large fragments (fag I, BssH II, Sfi I, Not I) identified Not I as giving interpretable banding patterns. Isolates were considered of different types if they differed by two or move bands. Sixteen distinct DNA types (A to P) were identified. Karyotyping was used an additional technique to compare strains with a common PFGE type. Most patients were colonized or infected with a single type at multiple body sites and over time. One PFGE type was shared by four patients housed in different areas of the institution at different times. For two of these four patients, the karyotype was also indistintuishable. Five patients were each colonized with two distinct types. The MIC of the strains studied were amphotericin B 0.5-1.0 mu g/ml (MIC(90) = 1.0 mu g/ ml), 5-fluorocytosine 0.25 --> 256 mu g/ml (MIC(90) = 2 mu g/ml), fluconazole 0.25 --> 128 mu g/ml (MIC(90) = 32 mu g/ml), and itraconazole 0.06-8.0 mu g/ml (MIC(90) = 2.0 mu g/ml). Molecular typing by PFGE using Not I digestion is It useful technique for epidemiological investigation as epidemiologically related isolates are generally identical and epidemiologically unrelated isolates are different by this method.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [1] CANDIDA (TORULOPSIS) GLABRATA
    SINNOTT, JT
    CULLISON, JP
    SWEENEY, MP
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1987, 8 (08): : 334 - 336
  • [2] TORULOPSIS-GLABRATA VAGINITIS - CLINICAL ASPECTS AND SUSCEPTIBILITY TO ANTIFUNGAL AGENTS
    REDONDOLOPEZ, V
    LYNCH, M
    SCHMITT, C
    COOK, R
    SOBEL, JD
    OBSTETRICS AND GYNECOLOGY, 1990, 76 (04): : 651 - 655
  • [3] Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis
    Miranda-Cadena, Katherine
    Marcos-Arias, Cristina
    Mateo, Estibaliz
    Manuel Aguirre, Jose
    Quindos, Guillermo
    Eraso, Elena
    ARCHIVES OF ORAL BIOLOGY, 2018, 95 : 100 - 107
  • [4] Candida (Torulopsis) glabrata septic arthritis
    Gumbo, T
    Isada, DM
    Muschler, GF
    Longworth, DL
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) : 208 - 209
  • [5] Screening protocol for Torulopsis (Candida) glabrata
    Land, G
    Burke, J
    Shelby, C
    Rhodes, J
    Collett, J
    Bennett, I
    Johnson, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (09) : 2300 - 2303
  • [6] Antifungal susceptibility testing of micafungin against Candida glabrata isolates
    Oliveira, Erica R.
    Fothergill, Annette
    Kirkpatrick, William R.
    Patterson, Thomas F.
    Redding, Spencer W.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2008, 105 (04): : 457 - 459
  • [7] Diversity and antifungal susceptibility of Norwegian Candida glabrata clinical isolates
    Andersen, Kari-Mette
    Kristoffersen, Anne Karin
    Ingebretsen, Andre
    Vikholt, Katharina Johnsen
    Ortengren, Ulf Thore
    Olsen, Ingar
    Enersen, Morten
    Gaustad, Peter
    JOURNAL OF ORAL MICROBIOLOGY, 2016, 8
  • [8] Evaluation of antifungal susceptibility in clinical isolates of the Candida glabrata complex
    Jesus, Filipa
    Barroso, Helena
    Nascimento, Teresa
    ANNALS OF MEDICINE, 2021, 53 : S93 - S94
  • [9] Evaluation of the E test for antifungal susceptibility testing of Candida glabrata
    Favel, A
    Chastin, C
    Thomet, AL
    Regli, P
    Michel-Nguyen, A
    Penaud, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (02) : 146 - 148
  • [10] Evaluation of the E Test for Antifungal Susceptibility Testing of Candida glabrata
    A. Favel
    C. Chastin
    A. L. Thomet
    P. Regli
    A. Michel-Nguyen
    A. Penaud
    European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 146 - 148